M
Martijn R. Meijerink
Researcher at University of Amsterdam
Publications - 158
Citations - 4713
Martijn R. Meijerink is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Irreversible electroporation & Medicine. The author has an hindex of 34, co-authored 141 publications receiving 3511 citations. Previous affiliations of Martijn R. Meijerink include University of Pisa & VU University Medical Center.
Papers
More filters
Journal ArticleDOI
Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
Hester J. Scheffer,Karin Nielsen,Marcus C. de Jong,Aukje A. J. M. van Tilborg,J.M. Vieveen,Arthur R A Bouwman,Sybren L. Meijer,Cornelis van Kuijk,Petrousjka van den Tol,Martijn R. Meijerink +9 more
TL;DR: Overall, the future of IRE for difficult-to-reach tumors appears promising, and in cases where other techniques are unsuitable, IRE is a promising modality for the ablation of tumors near bile ducts and blood vessels.
Journal ArticleDOI
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2) : a multicentre, patient-blinded, randomised controlled phase 2/3 trial
Jony van Hilst,Thijs de Rooij,Koop Bosscha,David J. Brinkman,Susan van Dieren,Marcel G. W. Dijkgraaf,Michael F. Gerhards,Ignace H. J. T. de Hingh,Tom M. Karsten,D.J. Lips,D.J. Lips,Misha D. P. Luyer,Olivier R. Busch,Sebastiaan Festen,Marc G. Besselink,Hendrik A. Marsman,Thomas M. van Gulik,Dennis A. Wicherts,Wietse J. Eshuis,Luna A Stibbe,Els Jm Nieveen van Dijkum,Janine E Van Hooft,Paul Fockens,Hanneke W. M. van Laarhoven,Johanna W. Wilmink,Marcel J Van de Vijver,Maarten F. Bijlsma,Joanne Verheij,C. Yung Nio,Krijn P. van Lienden,Geertjan van Tienhoven,Annuska Schoorlemmer,Geert-Jan Creemers,Casper H.J. van Eijck,Bas Groot Koerkamp,Marco J. Bruno,Ferry A.L.M. Eskens,Joost J. Nuyttens,Chulja Pek,George P. van der Schelling,Tom C.J. Seerden,Gijs A. Patijn,Vincent B. Nieuwenhuijs,Jan Willem B. de Groot,Bert A. Bonsing,Alexander L. Vahrmeijer,R.-J. Swijnenburg,J. Sven D. Mieog,Erwin van der Harst,Matthijs Den Dulk,Steven W.M. Olde Damink,Cees H. Dejong,Ronald Van Dam,Judith Mpgm De Vos,Mike Sl Liem,Cees J. H. M. van Laarhoven,Harry van Goor,Peter B. van den Boezem,B. Marion van der Kolk,Martijn Wj Stommel,John J. Hermans,Erwin J M van Geenen,Sandra A Radema,Lodewijk A.A. Brosens,Joris J. Scheepers,Daphne Roos,Djamilla Boerma,Wouter W. te Riele,Hjalmar C. van Santvoort,Thomas L. Bollen,Fanny Wit,I. Quintus Molenaar,Nadia Haj Mohammad,Maarten S. van Leeuwen,Annemarie Roele,Kees P De Jong,Vincent E de Meijer,Joost M. Klaase,Geert Kazemier,Babs M Zonderhuis,Freek Daams,Martijn R. Meijerink,Anouk E J Latenstein,L. Bengt van Rijssen,Carolijn L.M.A. Nota,Emo Van Halsema,Eran van Veldhuisen,Jantien A. Vogel,Kiki Janssen,Lianne Scholten,Lois A. Daamen,Marieke S. Walma,Marin Strijker,Mariska Prins,Maurice J. W. Zwart,Mustafa Suker,Steffi J.E. Rombouts,Timothy H. Mungroop,F. Vissers,Maarten Korrel +99 more
TL;DR: This multicentre, patient-blinded, parallel-group, randomised controlled phase 2/3 trial was performed in four centres in the Netherlands to assess whether laparoscopic pancreatoduodenectomy could reduce time to functional recovery compared with open pancreatic fistula.
Journal ArticleDOI
Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy.
Robert Hermans,Martijn R. Meijerink,Walter Van den Bogaert,A. Rijnders,Caroline Weltens,Philippe Lambin +5 more
TL;DR: In this paper, the authors investigated the value of CT-determined tumor perfusion as a predictive factor of local and regional failure and cause-specific survival in head-and-neck cancer treated by radiotherapy.
Journal ArticleDOI
Sunitinib for Treatment of Advanced Renal Cell Cancer: Primary Tumor Response
Astrid A.M. van der Veldt,Martijn R. Meijerink,Alfons J.M. van den Eertwegh,Axel Bex,Gijsbert C. de Gast,John B. A. G. Haanen,Epie Boven +6 more
TL;DR: Sunitinib can induce a significant reduction in volume of primary renal cell tumors and the role of nephrectomy before immunotherapy in patients with metastatic renal cell cancer will improve patient outcome.
Journal ArticleDOI
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
Bart Geboers,Hester J. Scheffer,Philip M. Graybill,Alette H. Ruarus,Sanne Nieuwenhuizen,Robbert S. Puijk,Petrousjka van den Tol,Rafael V. Davalos,Boris Rubinsky,Tanja D. de Gruijl,Damijan Miklavčič,Martijn R. Meijerink +11 more
TL;DR: High-voltage electrical pulses (HVEPs) in clinical oncology to treat solid tumors with irreversible electroporation (IRE) and electrochemotherapy (ECT) show immunogenic effects that could be augmented when combined with immunomodulatory drugs, a combination therapy the authors term electroimmunotherapy.